Breakthrough trial tests if common arthritis pill can actually heal damaged bones
NCT ID NCT05955066
Summary
This study is testing whether a medication called baricitinib can help repair existing bone damage in people with active rheumatoid arthritis. Sixty adult patients with active arthritis and visible bone erosion will take either the real drug or a placebo pill daily for 24 weeks. Researchers will use a special high-resolution scan to see if the drug leads to actual healing of the bone damage, which could be a significant step beyond just controlling symptoms.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RHEUMATOID ARTHRITIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
The Chinese University of Hong Kong
RECRUITINGHong Kong, Hong Kong, Hong Kong
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.